Shanxi C&Y Pharmaceutical Co.,Ltd. Posted 2.9 Million Yuan Net Loss in First Three Quarters of 2022

Shanxi C&Y Pharmaceutical Co.,Ltd. (山西仟源医药集团股份有限公司) (300254.SZ) reported a net loss of 2.9 million yuan in the first three quarters of 2022, reversing a net profit of 6.6 million yuan for the same period in the previous year.

Meanwhile, the company posted 633.9 million yuan in revenue, down 11.7% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 848.1 million yuan in total liabilities, with a liability-to-asset ratio of 51.4%.